Genome-wide CRISPR activation screening in senescent cells reveals SOX5 as a driver and therapeutic target of rejuvenation
Yaobin Jing,Xiaoyu Jiang,Qianzhao Ji,Zeming Wu,Wei Wang,Zunpeng Liu,Pedro Guillen-Garcia,Concepcion Rodriguez Esteban,Pradeep Reddy,Steve Horvath,Jingyi Li,Lingling Geng,Qinchao Hu,Si Wang,Juan Carlos Izpisua Belmonte,Jie Ren,Weiqi Zhang,Jing Qu,Guang-Hui Liu
DOI: https://doi.org/10.1016/j.stem.2023.09.007
IF: 23.9
2023-11-02
Cell Stem Cell
Abstract:Our understanding of the molecular basis for cellular senescence remains incomplete, limiting the development of strategies to ameliorate age-related pathologies by preventing stem cell senescence. Here, we performed a genome-wide CRISPR activation (CRISPRa) screening using a human mesenchymal precursor cell (hMPC) model of the progeroid syndrome. We evaluated targets whose activation antagonizes cellular senescence, among which SOX5 outperformed as a top hit. Through decoding the epigenomic landscapes remodeled by overexpressing SOX5, we uncovered its role in resetting the transcription network for geroprotective genes, including HMGB2. Mechanistically, SOX5 binding elevated the enhancer activity of HMGB2 with increased levels of H3K27ac and H3K4me1, raising HMGB2 expression so as to promote rejuvenation. Furthermore, gene therapy with lentiviruses carrying SOX5 or HMGB2 rejuvenated cartilage and alleviated osteoarthritis in aged mice. Our study generated a comprehensive list of rejuvenators, pinpointing SOX5 as a potent driver for rejuvenation both in vitro and in vivo.